{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T21:36:54Z","timestamp":1774474614129,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T00:00:00Z","timestamp":1674950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018337","name":"South Asian University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iLIVER"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.iliver.2023.01.002","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T02:49:07Z","timestamp":1675738147000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Free fatty acid-induced miR-22 inhibits gluconeogenesis via SIRT-1-mediated PGC-1\u03b1 expression in nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"2","author":[{"given":"Ajay K.","family":"Yadav","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2238-0249","authenticated-orcid":false,"given":"Teja Naveen","family":"Sata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daksh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amrendra K.","family":"Sah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit K.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Mrinalini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Musa","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kishor","family":"Pant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senthil K.","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.iliver.2023.01.002_bib1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200422422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"Browning","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.iliver.2023.01.002_bib2","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1053\/gast.2002.33573","article-title":"Nonalcoholic fatty liver disease","volume":"122","author":"Clark","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.iliver.2023.01.002_bib3","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.iliver.2023.01.002_bib4","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference","volume":"37","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.iliver.2023.01.002_bib5","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1101\/gad.2076411","article-title":"Gene program-specific regulation of PGC-1{alpha} activity","volume":"25","author":"Schmidt","year":"2011","journal-title":"Genes Dev"},{"key":"10.1016\/j.iliver.2023.01.002_bib6","first-page":"156","article-title":"A\u00a0review of Sirt1 and Sirt1 modulators in cardiovascular and metabolic diseases, Recent Patents Cardiovasc","volume":"3","author":"Pillarisetti","year":"2008","journal-title":"Drug Discov"},{"key":"10.1016\/j.iliver.2023.01.002_bib7","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1101\/gad.1467506","article-title":"Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction","volume":"20","author":"Haigis","year":"2006","journal-title":"Genes Dev"},{"key":"10.1016\/j.iliver.2023.01.002_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20070140","article-title":"Sirtuins in mammals: insights into their biological function","volume":"404","author":"Michan","year":"2007","journal-title":"Biochem J"},{"key":"10.1016\/j.iliver.2023.01.002_bib9","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1210\/me.2007-0079","article-title":"Sirtuin functions in health and disease","volume":"21","author":"Yamamoto","year":"2007","journal-title":"Mol Endocrinol Baltim Md"},{"key":"10.1016\/j.iliver.2023.01.002_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.636204","article-title":"N-acetyl cysteine ameliorates high-fat diet-induced nonalcoholic fatty liver disease and intracellular triglyceride accumulation by preserving mitochondrial function","volume":"12","author":"Hang","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.iliver.2023.01.002_bib11","doi-asserted-by":"crossref","first-page":"G979","DOI":"10.1152\/ajpgi.00169.2012","article-title":"PGC-1\u03b1 overexpression results in increased hepatic fatty acid oxidation with reduced triacylglycerol accumulation and secretion","volume":"303","author":"Morris","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.iliver.2023.01.002_bib12","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\u201d","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.iliver.2023.01.002_bib13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1152\/physrev.00024.2006","article-title":"Disordered lipid metabolism and the pathogenesis of insulin resistance","volume":"87","author":"Savage","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.iliver.2023.01.002_bib14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev.bi.49.070180.002143","article-title":"Regulation of hepatic fatty acid oxidation and ketone body production","volume":"49","author":"McGarry","year":"1980","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.iliver.2023.01.002_bib15","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1053\/gast.2001.23256","article-title":"Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities","volume":"120","author":"Sanyal","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.iliver.2023.01.002_bib16","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/hep.22569","article-title":"Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression","volume":"48","author":"Cheung","year":"2008","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.iliver.2023.01.002_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.gde.2006.02.012","article-title":"Gene regulation by microRNAs","volume":"16","author":"Carthew","year":"2006","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.iliver.2023.01.002_bib18","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.iliver.2023.01.002_bib19","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.iliver.2023.01.002_bib20","doi-asserted-by":"crossref","first-page":"52361","DOI":"10.1074\/jbc.C400438200","article-title":"MicroRNA-143 regulates adipocyte differentiation","volume":"279","author":"Esau","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.iliver.2023.01.002_bib21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/hep.25846","article-title":"MicroRNA-27b is a regulatory hub in lipid metabolism and is altered in dyslipidemia","volume":"57","author":"Vickers","year":"2013","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.iliver.2023.01.002_bib22","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/hep.25632","article-title":"Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha","volume":"56","author":"Wang","year":"2012","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.iliver.2023.01.002_bib23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fphys.2012.00068","article-title":"MicroRNA regulation of SIRT1","volume":"3","author":"Yamakuchi","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/j.iliver.2023.01.002_bib24","doi-asserted-by":"crossref","first-page":"13421","DOI":"10.1073\/pnas.0801613105","article-title":"miR-34a repression of SIRT1 regulates apoptosis","volume":"105","author":"Yamakuchi","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.iliver.2023.01.002_bib25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.redox.2017.03.006","article-title":"Butyrate induces ROS-mediated apoptosis by modulating miR-22\/SIRT-1 pathway in hepatic cancer cells","volume":"12","author":"Pant","year":"2017","journal-title":"Redox Biol"},{"key":"10.1016\/j.iliver.2023.01.002_bib26","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.livres.2020.06.001","article-title":"MiR-22 as a metabolic silencer and liver tumor suppressor","volume":"4","author":"Wang","year":"2020","journal-title":"Liver Res"},{"key":"10.1016\/j.iliver.2023.01.002_bib27","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1159\/000480212","article-title":"Mir-22-3p inhibits arterial smooth muscle cell proliferation and migration and neointimal hyperplasia by targeting HMGB1 in arteriosclerosis obliterans, cell","volume":"42","author":"Huang","year":"2017","journal-title":"Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol"},{"key":"10.1016\/j.iliver.2023.01.002_bib28","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/CIRCULATIONAHA.118.033042","article-title":"miR-22 in smooth muscle cells: a potential therapy for cardiovascular disease","volume":"137","author":"Huang","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.iliver.2023.01.002_bib29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/08830185.2017.1281272","article-title":"MicroRNA-22-3p as a novel regulator and therapeutic target for autoimmune diseases","volume":"36","author":"Wang","year":"2017","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.iliver.2023.01.002_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120625","article-title":"Free fatty acid-induced miR-181a-5p stimulates apoptosis by targeting XIAP and Bcl2 in hepatic cells","volume":"301","author":"Yadav","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.iliver.2023.01.002_bib31","doi-asserted-by":"crossref","DOI":"10.3791\/55178","article-title":"Optimized analysis of in vivo and in vitro hepatic steatosis","author":"Cui","year":"2017","journal-title":"JoVE J Vis Exp"},{"key":"10.1016\/j.iliver.2023.01.002_bib32","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/2211-5463.13026","article-title":"MiR-22 modulates the expression of lipogenesis-related genes and promotes hepatic steatosis in vitro","volume":"11","author":"Yang","year":"2020","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.iliver.2023.01.002_bib33","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"Suppl 2","key":"10.1016\/j.iliver.2023.01.002_bib34","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s12072-013-9468-6","article-title":"Immune and inflammatory pathways in NASH","volume":"7","author":"Ganz","year":"2013","journal-title":"Hepatol Int"},{"key":"10.1016\/j.iliver.2023.01.002_bib35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-0030-1267539","article-title":"Novel insights into the pathophysiology of nonalcoholic fatty liver disease","volume":"30","author":"Feldstein","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.iliver.2023.01.002_bib36","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1053\/j.gastro.2012.02.003","article-title":"Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications","volume":"142","author":"Cusi","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.iliver.2023.01.002_bib37","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrgastro.2013.149","article-title":"From NAFLD to NASH to cirrhosis-new insights into disease mechanisms","volume":"10","author":"Wree","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.iliver.2023.01.002_bib38","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A\u00a0lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.iliver.2023.01.002_bib39","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1210\/er.2006-0037","article-title":"Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism","volume":"27","author":"Handschin","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/j.iliver.2023.01.002_bib40","doi-asserted-by":"crossref","first-page":"40265","DOI":"10.1074\/jbc.M206324200","article-title":"Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and -gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha","volume":"277","author":"Huss","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.iliver.2023.01.002_bib41","doi-asserted-by":"crossref","first-page":"26597","DOI":"10.1074\/jbc.M301850200","article-title":"Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells","volume":"278","author":"St-Pierre","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.iliver.2023.01.002_bib42","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.01.026","article-title":"PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells","volume":"66","author":"Valle","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.iliver.2023.01.002_bib43","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.iliver.2023.01.002_bib44","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00394-017-1472-5","article-title":"High-fat diet inhibits PGC-1\u03b1 suppressive effect on NF\u03baB signaling in hepatocytes","volume":"57","author":"Barroso","year":"2018","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.iliver.2023.01.002_bib45","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3390\/nu10081060","article-title":"Delphinidin ameliorates hepatic triglyceride accumulation in human HepG2 cells, but not in diet-induced obese mice","volume":"10","author":"Parra-Vargas","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.iliver.2023.01.002_bib46","doi-asserted-by":"crossref","first-page":"118","DOI":"10.25000\/acem.623975","article-title":"Effect of palmitate-induced steatosis on paraoxonase-1 and paraoxonase-3 enzymes in human-derived liver (HepG2) cells","volume":"4","author":"\u00d6zg\u00fcn","year":"2019","journal-title":"Arch Clin Exp Med"},{"key":"10.1016\/j.iliver.2023.01.002_bib47","doi-asserted-by":"crossref","first-page":"24336","DOI":"10.1074\/jbc.M602177200","article-title":"p38 Mitogen-activated protein kinase mediates free fatty acid-induced gluconeogenesis in hepatocytes","volume":"281","author":"Collins","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.iliver.2023.01.002_bib48","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0952-3278(97)90492-0","article-title":"Regulation of gene transcription by fatty acids, fibrates and prostaglandins: the phosphoenolpyruvate carboxykinase gene as a model","volume":"57","author":"Forest","year":"1997","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.iliver.2023.01.002_bib49","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1476-511X-11-66","article-title":"Fatty acids-stress attenuates gluconeogenesis induction and glucose production in primary hepatocytes","volume":"11","author":"Budick-Harmelin","year":"2012","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.iliver.2023.01.002_bib50","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF02634356","article-title":"Expression of some hepatocyte-like functional properties of WRL-68 cells in culture, in Vitro Cell","volume":"30A","author":"Guti\u00e9rrez-Ruiz","year":"1994","journal-title":"Dev Biol Anim"},{"key":"10.1016\/j.iliver.2023.01.002_bib51","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1440-1746.2008.05733.x","article-title":"Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes","volume":"24","author":"Ricchi","year":"2009","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.iliver.2023.01.002_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-230X-13-3","article-title":"Independent association of HbA1c and nonalcoholic fatty liver disease in an elderly Chinese population","volume":"13","author":"Ma","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.iliver.2023.01.002_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097136","article-title":"HCC development is associated to peripheral insulin resistance in a mouse model of NASH","volume":"9","author":"De Minicis","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.iliver.2023.01.002_bib54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metabol"},{"key":"10.1016\/j.iliver.2023.01.002_bib55","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1172\/JCI63455","article-title":"MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis","volume":"122","author":"Tsai","year":"2012","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.iliver.2023.01.002_bib56","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/acel.12135","article-title":"Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT","volume":"12","author":"Choi","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.iliver.2023.01.002_bib57","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1136\/gutjnl-2016-312869","article-title":"miRNA-132 induces hepatic steatosis and hyperlipidaemia by synergistic multitarget suppression","volume":"67","author":"Hanin","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.iliver.2023.01.002_bib58","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nm.3200","article-title":"MicroRNA-30c reduces hyperlipidemia and atherosclerosis by decreasing lipid synthesis and lipoprotein secretion","volume":"19","author":"Soh","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.iliver.2023.01.002_bib59","article-title":"miR-146a improves hepatic lipid and glucose metabolism by targeting MED1","volume":"45","author":"K","year":"2020","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.iliver.2023.01.002_bib60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fphar.2017.00003","article-title":"New microRNA biomarkers for drug-induced steatosis and their potential to predict the contribution of drugs to non-alcoholic fatty liver disease","volume":"8","author":"L\u00f3pez-Riera","year":"2017","journal-title":"Front Pharmacol"},{"issue":"131","key":"10.1016\/j.iliver.2023.01.002_bib61","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1042\/CS20171368","article-title":"Loss of microRNA-22 prevents high-fat diet induced dyslipidemia and increases energy expenditure without affecting cardiac hypertrophy","volume":"1979","author":"Diniz","year":"2017","journal-title":"Clin Sci Lond Engl"},{"key":"10.1016\/j.iliver.2023.01.002_bib62","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1039\/c1mb05041a","article-title":"Comprehensive miRNome and in silico analyses identify the Wnt signaling pathway to be altered in the diabetic liver","volume":"7","author":"Kaur","year":"2011","journal-title":"Mol Biosyst"}],"container-title":["iLIVER"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772947823000038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772947823000038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:36:28Z","timestamp":1757424988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772947823000038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2772947823000038"],"URL":"https:\/\/doi.org\/10.1016\/j.iliver.2023.01.002","relation":{},"ISSN":["2772-9478"],"issn-type":[{"value":"2772-9478","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Free fatty acid-induced miR-22 inhibits gluconeogenesis via SIRT-1-mediated PGC-1\u03b1 expression in nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"iLIVER","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iliver.2023.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of Tsinghua University Press.","name":"copyright","label":"Copyright"}]}}